Cibus Inc. (CBUS)
2.71
0.27 (11.07%)
At close: Jan 15, 2025, 3:59 PM
2.72
0.37%
After-hours Jan 15, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 2.44 |
| Market Cap | 80.13M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -45.95 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.98 |
| Volume | 102,022 |
| Avg. Volume (20D) | 163,365 |
| Open | 2.56 |
| Previous Close | 2.44 |
| Day's Range | 2.44 - 2.71 |
| 52-Week Range | 2.17 - 23.18 |
| Beta | undefined |
About CBUS
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production result...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 20, 2017
Employees 183
Stock Exchange NASDAQ
Ticker Symbol CBUS
Website https://www.cibus.com
Analyst Forecast
According to 3 analyst ratings, the average rating for CBUS stock is "Buy." The 12-month stock price forecast is $23.5, which is an increase of 767.16% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Cibus Inc. is scheduled to release its earnings on Mar 20, 2025,
during market hours.
Analysts project revenue of $1.75M, reflecting a 58.66% YoY growth and earnings per share of -0.85, making a -33.07% decrease YoY.
Analysts project revenue of $1.75M, reflecting a 58.66% YoY growth and earnings per share of -0.85, making a -33.07% decrease YoY.
2 months ago ·
Source
+8.9%
Cibus shares are trading higher. HC Wainwright & C...
Unlock content with
Pro Subscription
2 months ago ·
Source
+20%
Cibus shares are trading higher after the company reported better-than-expected Q3 sales result.
